Kontafarma China (01312) Publishes October 2025 Monthly Return
Bulletin Express
Nov 04, 2025
Kontafarma China Holdings Limited (01312) has submitted its monthly return for the period ended 31 October 2025. There was no change in the authorized share capital, which remains at 100,000,000,000 ordinary shares at a par value of HKD 0.002 per share. The total authorized share capital remains HKD 200,000,000.
The total number of issued shares (excluding treasury shares) also showed no change, standing at 5,588,571,777 shares. The report further confirms no issuance or movement in share options, warrants, or other convertible instruments during the month.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.